期刊文献+

泌尿系统恶性肿瘤副肿瘤综合征的临床特点及意义 被引量:6

Clinical features of urological malignancies with paraneoplastic syndromes
原文传递
导出
摘要 目的 探讨泌尿系统恶性肿瘤(肾细胞癌、前列腺癌、膀胱癌)中副肿瘤综合征(PNS)的临床特点和发病率,分析其与预后的相关性.方法 对2008年1月-2009年12月经手术和病理确诊为肾细胞癌的464例住院病例、2005-2010年确诊为前列腺癌的562例和膀胱癌的647例患者进行回顾性住院资料与随访分析.结果 464例肾细胞癌中发生PNS 156例(33.6%),主要表现为贫血(26.3%,41/156)、高血压(24.4%,38/156)、发热(21.8%,34/156)、红细胞增多症(19.2%,30/156)、Stauffer综合征(17.3%,27/156)、食欲不振、乏力、体重减轻(15.4%,24/156)、红细胞沉降率加快(12.8%,20/156)、白细胞增多症(8.3%,13/156)、高钙血症(5.1%,8/156)、糖代谢紊乱(1.9%,3/156)、性激素异常(0.6%,1/156)等.肾细胞癌中发生PNS 156例,肿瘤平均直径5.5 em,其余平均直径4.7(P<0.01).2例(0.36%,2/562)前列腺癌患者血钾及血糖水平发生异常,均合并多处骨转移,应用全雄激素阻断3个月后血钾及血糖水平恢复正常.在647例膀胱癌患者中尚未发现文献所述PNS表现.结论 泌尿系统恶性肿瘤PNS的发病率由高到低依次为肾细胞癌、前列腺?儋 癌、膀胱癌.PNS的临床表现复杂多样,个别与肿瘤导致异位激素分泌有关,早期诊断后手术切除原发病灶后PNS可消失或有效改善.伴发PNS的患者较不伴发者预后不良. Objective To investigate the clinical features of paraneoplastic syndromes (PNS) in patients with renal, prostate and bladder cancer and conduct a brief prognostic analysis. Methods From 2008 to 2010, 464 patients of renal cell carcinoma (RCC) confirmed by operation and pathology were reviewed retrospectively. And 562 cases of patients with prostate cancer and 647 with bladder cancer from 2005 to 2010 were also analyzed respectively. Results Among all cases, 156 (33.6%)patients were diagnosed with PNS manifesting with anemia, hypertension, fever, polycythemia, Stauffer's syndrome, fatigue, weight loss, anorexia, leukocytosis and hypercalcemia, etc. Two prostate cancer patients had the elevated levels of calcemia and blood glucose respectively. However, no specific clinical presentation in bladder cancer was found to be associated with PNS in this study. Conclusions RCC is the most frequent urological malignancy with PNS. But prostate cancer with PNS is very uncommon and bladder cancer is extremely rare. Most paraneoplastic signs predicate a poor prognosis for the patients.
出处 《中华医学杂志》 CAS CSCD 北大核心 2010年第48期3411-3414,共4页 National Medical Journal of China
关键词 副肿瘤综合征 泌尿生殖系统肿瘤 发病率 预后 Paraneoplastic syndromes Urogenital neoplasms Incidence Prognosis
  • 相关文献

参考文献14

  • 1Sacco E,Pinto F,Sasso F,et al.Paraneoplastic syndromes in patients with urological malignancies.Urol Int,2009,83:1-11.
  • 2Kirkali Z,Esen AA,Kirkali G,et al.Ferritin:a tumor marker expressed by renal cell carcinoma.Eur Urol,1995,28:131-134.
  • 3Motzer RJ,Mazumdar M,Bacik J,et al.Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.J Clin Oncol,1999,17:2530-2540.
  • 4Zucchetto A,Dal Maso L,Tavani A,et al.History of treated hypertension and diabetes mellitus and risk of renal cell cancer.Ann Oncol,2007,18:596-600.
  • 5Wiesener MS,Seyfarth M,Warnecke C,et al.Paraneoplastic erythrocytosis associated with an inactivating point mutation of the von Hippel-Lindau gene in a renal cell carcinoma.Blood,2002,99:3562-3565.
  • 6Michael A,Politi E,Havranek E,et al.Prognostic significance of erythropoietin expression in human renal cell carcinoma.BJU Int,2007,100:291-294.
  • 7高旭,任善成,侯建国,许传亮,王林辉,孙颖浩.Stauffer综合征44例报告[J].中华泌尿外科杂志,2009,30(11):735-737. 被引量:5
  • 8Kawai Y,Matsuyama H,Korenaga Y,et al.Preoperative erythrocyte sedimentation rate is an independent prognostic factor in Japanese patients with localized clear cell renal cell carcinoma.Urol Int,2009,83:306-310.
  • 9Pepper K,Jaowattana U,Starsiak MD,et al.Renal cell carcinoma presenting with paraneoplastic hypercalcemic coma:a case report and review of the literature.J Gen Intern Med,2007,22:1042-1046.
  • 10Chasan SA,Pothel LR,Huben RP.Management and prognostic significance of hypercalcemia in renal cell carcinoma.Urology,1989,33:167-170.

共引文献4

同被引文献28

  • 1王志强,张力,张海鸥,朱美琴,许然.原发性小肠腺癌50例临床分析[J].临床肿瘤学杂志,2006,11(5):358-360. 被引量:2
  • 2刘晖,唐丽瓯,纪祥瑞.具有恶性潜能的肾上皮样血管平滑肌脂肪瘤研究进展[J].实用肿瘤学杂志,2007,21(4):378-380. 被引量:4
  • 3Vardiman JW, Thiele J, Arber the World Health Organization neoplasms and acute leukemia: Blood, 2009,114(5 ) : 937-951. DA, et al The 2008 revision of (WHO) classification of myeloid rationale and important changes.
  • 4Keidar Z, Gurman-Balbir A, Gaitini D, et al. Fever of unknown origin: the role of 18F-FDG PET/CT. J Nucl Med, 2008,49(12) : 1980-1985.
  • 5Petersdolf RG, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine, 1961,40( 1 ) : 1-30.
  • 6Bleeker-Rovers CP, van der Meer JW, Oyen WJ, et al. Fever of unknown origin. Semin Nucl Med, 2009,39(2):81-87.
  • 7Stang A, Stegmaier C, Eisinger B, et al. Descriptive epidemiology of small intestinal malignancies : the German Cancer Registry experience. Br J Cancer, 1999, 80(9): 1440-1444.
  • 8Verma D, Stroehlein JR. Adenocarcinoma of the small bowel: a 60-yr perspective derived from M. D. Anderson Cancer Center Tumor Registry'. Am J Gastroenterol, 2006, 101 (7) : 1647-1654.
  • 9Hong SH, Koh YH, Rho SY, et al. Primary Adenncarcinoma of the small intestine: presentation, prognostic factors and clinical outcome. Jpn J Clin Oncol, 2009,39( 1 ) : 54-61.
  • 10Halfdmmrson TR, Quevedo F, McWilliams RR. Small bowel adenocarcinoma : a review of 491 cases (abstract). J Clin Oncol, 2006,24 : 209s.

引证文献6

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部